NCT04069130View on ClinicalTrials.gov

Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
Cardiovascular Diseases
Interventions
DRUG

400 mg of BIA 5-1058

1 x 400 mg capsule Oral, Fasted

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT04069130 - Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058 | Biotech Hunter | Biotech Hunter